Appreciating the best.

A. Casey

DOI: https://doi.org/10.7748/paed.18.4.3.s1

2006-05-01

Paediatric Nursing

Abstract:

What problem does this paper attempt to address?

Self‐nonself discrimination and repertoire selection of human T cells differentiated in an HLA‐semiallogeneic environment following bone marrow transplantation for severe combined immunodeficiency

C. Knobloch,S. Goldmann,W. Friedrich

DOI: https://doi.org/10.1002/eji.1830211026

1991-10-01

European Journal of Immunology

Abstract:We have analyzed allorecognition, HLA restriction and T cell receptor (TcR) diversity in an HLA‐heterozygous (HLA‐DRw6,7) severe combined immunodeficiency (SCID) patient whose T cell system had been repopulated by HLA‐homozygous (HLA‐DRw6) paternal T cells following T cell‐depleted bone marrow transplantation (BMT). Donor origin of T cells and host origin of antigen‐presenting cells (APC) in peripheral blood and BM is shown by HLA typing of separated cell populations and two‐color immunofluorescence using an anti‐HLA monoclonal antibody (mAb). Peripheral blood lymphocytes (PBL) from the chimeric patient proliferate normally against PHA, anti‐TcR/CD3 mAb, pooled allogeneic PBL, and also against the recall antigen (Ag) tetanus toxoid and purified protein derivative of tuberculin (PPD) following immunization, suggesting recognition by donor (DRw6) T cells of Ag presented by host (DRw6,7) APC. PPD‐specific cytotoxic T lymphocytes generated in vitro from patient PBL post‐BMT display specific cytotoxicity against targets expressing DRw6 and DR7, but not against DR‐mismatched targets, suggesting that HLA restriction of Ag recognition may occur through determinants expressed by the host and not by the donor. Donor T cells differentiated in the HLA‐semiallogeneic host show specific proliferative and cytotoxic responses against HLA‐mismatched stimulators, but not against stimulators taken from the host, expressing the host‐specific HLA‐haplotype, or expressing the host‐specific HLA‐DR7 antigens. Compared to T cells directly taken from the donor, differentiation of donor T cells in the host is associated with a significant decrease of T cells expressing TcR Vβ5 and Vα2 determinants, while no differences in the abundance of of TcR Vβ6, Vβ8 and Vβ12 subsets were noticed. We conclude that allorecognition, major histocompatibility complex (MHC) restriction and TcR diversity generation of human T cells can be modulated through differentiation in an MHC‐different environment, as had been previously shown to be the case in murine model systems.
[The ultrastructure of the pineal body in the parakeet Melopsittacus undulatus with special reference to cellular types and their functions].

W. B. Quay,A. Renzoni,R. M. Eakin

1968-10-01

Abstract:
Photocatalytic oxidation of trace carbamazepine in aqueous solution by visible-light-driven Znln2S4: Performance and mechanism.

L. Bo,Kebo He,Na Tan,B. Gao,Qiqi Feng,Jiadong Liu,Lei Wang

DOI: https://doi.org/10.1016/j.jenvman.2016.12.050

IF: 8.7

2017-04-01

Journal of Environmental Management

Abstract:
[Common Variable Immunodeficiency: Report of Two Cases and Literature Review].

Jian-ping Li,Hui-jun Wang,Lei Zhang,Ren-chi Yang,Feng-kui Zhang

DOI: https://doi.org/10.3760/cma.j.issn.0253-2727.2009.02.010

2009-01-01

Abstract:OBJECTIVE To promote the awareness of common variable immunodeficiency (CVID). METHODS Report two cases of CVID and review related literature. RESULTS The two CVID patients were manifested recurrent infections of respiratory and digestive tract, splenomegaly, significantly reduced serum immunoglobulin, since adolescence. They were treated with intravenous gammaglobulin, anti-infection and symptomatic therapies and the diseases were well controlled. Case 1 was diagnosed as with spleen peripheral T cell lymphoma after splenectomy. Case 2 developed nutritional megaloblastic anemia resulting from repeated digestive tract infections. CONCLUSION CVID is a heterogeneous group of diseases with later-onset, characterized by hypogammaglobulinemia and recurrent bacterial infections. Early diagnosis and regular treatment may improve the prognosis.
Association Between Coeliac Disease and Risk of Any Malignancy and Gastrointestinal Malignancy

Yaling Han,Wuzhen Chen,Peiwei Li,Jun Ye

DOI: https://doi.org/10.1097/md.0000000000001612

IF: 1.6

2015-01-01

Medicine

Abstract:Coeliac disease (CD) is reported to be associated with risk of malignancy; however, this association remains unclear. We aimed to systematically evaluate the association between CD and risk of all malignancies as well as gastrointestinal (GI) malignancy specifically. The PUBMED and EMBASE databases were searched to identify eligible studies from 1960 to March 2015, without restriction. Two reviewers independently performed the study inclusion and data extraction methods. Odds ratios (ORs), risk ratios, or standardized incidence ratios were pooled using either a fixed- or a random-effects model. Sensitivity and subgroup analyses were used to explore sources of heterogeneity. A total of 17 studies were included in this meta-analysis. The pooled OR for risk of all malignancies was 1.25 (95% confidence interval [CI] 1.09-1.44), whereas the pooled OR for risk of GI malignancy was 1.60 (95% CI 1.39-1.84) and suggested an inverse association with CD. Moreover, patients with CD were at a higher risk of esophageal cancer (pooled OR = 3.72, 95% CI 1.90-7.28) and small intestinal carcinoma (pooled OR = 14.41, 95% CI 5.53-37.60), whereas no significant associations were observed for other GI cancers, including gastric, colorectal, liver, and pancreatic cancers. Subgroup analyses also indicated that the results were influenced by the CD diagnostic method, as well as the follow-up time after CD diagnosis. CD was associated with increased risk of all malignancies as well as GI malignancies, including esophageal cancer and small intestinal carcinoma.
P232 Common variable immunodeficiency-associated enteropathy in consecutive patients from a tertiary hospital

J Miranda-Bautista,M Di Natale,M A Mejía González,H Martínez Lozano,H Balastegui Martín,I Marín-Jiménez,E Fernández Cruz,R Bañares,L Menchén

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0362

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background Common variable immunodeficiency (CVID) patients may develop intestinal inflammatory involvement in 9-20% of cases, although its diagnosis, management and prognosis are not well established. Methods We performed a transversal study with retrospective data collection. We reviewed all clinical records from consecutive adult CVID patients followed in Gregorio Marañón Hospital (Spain) from January 1st 1990 to January 1st 2023. A diagnosis of CVID-associated enteropathy (CVID-E) was established if patchy intestinal inflammation (Crohn-like pattern) or colonic inflammation (ulcerative colitis-like pattern) was demonstrated, or villous atrophy was observed in duodenal biopsies (celiac-like pattern) or inflammatory infiltrate was observed in colonic biopsies (microscopic colitis-like pattern). Differences between CVID-E patients and the rest of the CVID cohort were evaluated using chi-square and T student methods, when appropriate. Results 89 patients with confirmed CVID following ESID criteria were included. Patients’ characteristics are summarised in Table 1. All patients were receiving intravenous or subcutaneous Igs and reached an Ig G trough level >1000 mg/dL. CVID-E was diagnosed in 26 patients (29,2%), at a median of 6,4 years after CVID diagnosis. Surprisingly, 10 patients (38,5%) were diagnosed with CVID-E before or at the same time of CVID diagnosis. 5 patients were dead (19,2%), and the causes of death were gastric cancer (1 patient), liver complications (1), infectious complications (1), enteropathy (1) and unknown cause (1). 73,1% suffered from GI infections (Giardia lamblia, Campylobacter jejuni and Clostridioides difficile were the most frequent agents). The most frequent pattern of the disease was Crohn-like disease (Figure 1). Although exclusive celiac-like pattern was found in only 3 patients, 5 Crohn-like, 4 UC-like and 2 microscopic colitis-like pattern patients also presented duodenal atrophy. Unexpectedly, 46,2% of CVID-E patients suffered from concomitant liver involvement. Eight patients received corticosteroids, 2 azathioprine and 1 patient received infliximab and subsequent ustekinumab. One patient needed subtotal colectomy, another ileal resection and another patient received a terminal colostomy due to severe perianal disease. CVID-E patients presented statistically more frequent liver involvement, more GI infections, and a tendency towards more GI cancer. Conclusion CVID-E is frequent among CVID patients. These patients suffer from more GI infections, liver involvement and probably more GI cancer. Screening of levels of Igs at diagnosis of IBD and celiac disease is advisable as CVID diagnosis can occur at the same time or even after enteropathy diagnosis.

gastroenterology & hepatology
Paucity of gastrointestinal plasma cells in common variable immunodeficiency

Jan Willem N. Marsden,Miangela M. Laclé,Mirjam Severs,Helen Louisa Leavis

DOI: https://doi.org/10.1097/aci.0000000000001040

2024-10-10

Current Opinion in Allergy and Clinical Immunology

Abstract:Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency, affecting about 1 in every 25 000 Caucasians [1] . These patients have a marked reduction in serum levels of both immunoglobulin G (IgG) and either immunoglobulin A (IgA) or immunoglobulin A (IgM) as a result of a B-cell dysfunction [2] . Burden of disease is high in CVID, the annual mean rate of disability adjusted life years (DALY) in the cohort associated with the European Society for Immunodeficiencies (ESID) was 36 785 [3] . This ranks CVID in the top 10 of diseases with the highest individual burden. CVID can result in infectious and noninfectious inflammatory complications [4] . CVID patients with inflammatory complications have even lower quality of life and significantly higher mortality rates than those with only infections [5,6] .

immunology,allergy
[Common variable immunodeficiency disorders: Part 2. Updated clinical manifestations and therapeutic management]

J F Viallard,B Lebail,H Begueret,C Fieschi

DOI: https://doi.org/10.1016/j.revmed.2020.12.015

Abstract:Common variable immunodeficiency disorders (CVID) are the most common symptomatic primary antibody deficiency in adults with an estimated prevalence of 1/25,000. The most frequent clinical manifestations are upper respiratory tract infections (including pneumonia, bronchitis, and sinusitis) predominantly with Streptococcus pneumoniae or H. influenzae. However, CVID are complicated in 20 to 30 % of cases of non-infectious manifestations which have been well characterized in recent years. Several complications can be observed including autoimmune, lymphoproliferative, granulomatous or cancerous manifestations involving one or more organs. These complications, mostly antibody-mediated cytopenias, are correlated with a decrease in the number of circulating switched memory B cells. Replacement therapy with polyvalent gammaglobulins has greatly improved the prognosis of these patients but it remains poor in the presence of digestive complications (especially in the case of chronic enteropathy and/or porto-sinusoidal vascular disease), pulmonary complications (bronchiectasis and/or granulomatous lymphocytic interstitial lung disease) and when progression to lymphoma. Much progress is still to be made, in particular on the therapeutic management of non-infectious complications which should benefit in the future from targeted treatments based on knowledge of genetics and immunology.
Evidence for possible increase of sodium channel open time and involvement of Na/Ca exchange by a new positive inotropic drug: OPC-8212.

D. Lathrop,A. Schwartz

DOI: https://doi.org/10.1016/0014-2999(85)90016-0

IF: 5.195

1985-11-19

European Journal of Pharmacology

Abstract:
On Branciari's theorem for weakly compatible mappings

C. Vetro

DOI: https://doi.org/10.1016/j.aml.2010.02.011

IF: 4.294

2010-06-01

Applied Mathematics Letters

Abstract:
Unmasking Common Variable Immunodeficiency: A Case Of Chronic Diarrhea

L. Mazahreh,E. Yee,A. Jefferson,S. Nawaz,S. Keskin,J. Kennedy

DOI: https://doi.org/10.1016/j.anai.2024.08.707

2024-10-28

Abstract:Introduction Common Variable Immunodeficiency (CVID) is often underdiagnosed in adults. We present a case of a 55-year-old man with chronic diarrhea and abdominal pain, diagnosed with CVID following a gastrointestinal biopsy. Case Description A 55-year-old man presented with two weeks of abdominal pain and watery diarrhea. Initial labs revealed a WBC count of 7 x 10^9/L, and a CT scan showed a non-specific dilated loop of bowel. He was discharged with loperamide treatment but returned a week later with persistent abdominal pain and new-onset bloody diarrhea. His WBC count was 8 x 10^9/L. Stool cultures were positive for Giardia , and metronidazole was given. Endoscopy showed nodularity in the duodenum. Biopsy showed intact villous architecture, lymphoid aggregates with reactive germinal centers, and absent plasma cells. The pathologist recommended a work-up for CVID, which showed low IgG 169 mg/dL, IgM <13 mg/dL, and IgA <20 mg/dL, with low CD19+ B cells (150/mcL), CD4+ T cells (226/mcL) and CD27+B cells (5.7/mcL), and poor vaccination responses. Genetic testing revealed a pathogenic heterozygous mutation in TNFRSF13B: c.310T>C (p.Cys104Arg). He was diagnosed with CVID and started IVIG therapy, with infectious and symptomatic resolution Discussion This case emphasizes the need for timely and thorough diagnostic evaluations in patients with persistent gastrointestinal symptoms and recurrent infections. CVID should be considered in adults with chronic diarrhea, Giardia lamblia infection, or with endoscopic findings that lack plasma cells. Accurate diagnosis and initiation of IVIG therapy can significantly improve patient outcomes.

immunology,allergy
The impact of immune dysregulation on the risk of malignancy in common variable immunodeficiency: insights from a multicenter study

Marta Dafne Cabañero-Navalon,Victor Garcia-Bustos,Héctor Balastegui-Martin,Carmen Bracke,Lourdes Mateu,Xavier Solanich,Juan Luis Carrillo-Linares,Angel Robles-Marhuenda,Francesc Puchades,Ana Pelaez Ballesta,Nuria Lopez-Osle,Miguel Ángel Torralba-Cabeza,Ana María Bielsa Masdeu,Jorge Gil Niño,Nuria Tornador Gaya,Guillem Pascual Castellanos,Rosario Sánchez-Martínez,José Manuel Barragán-Casas,Andrés González-García,José Luis Patier de la Peña,Daniel López-Wolf,Antonia Mora Rufete,Alba Canovas Mora,Pedro Moral Moral

DOI: https://doi.org/10.3389/fimmu.2024.1465159

2024-10-16

Abstract:Background: Common Variable Immunodeficiency (CVID) represents a heterogenic group of primary immunodeficiencies (PID) characterized by impaired antibody production and susceptibility to infections. Non-infectious complications, such as autoimmune diseases, lymphoproliferative disorders, and malignancies, now significantly impact prognosis. Moreover, both hematologic and solid organ malignancies are more frequently observed in CVID patients compared to other PIDs. The risk factors for carcinogenesis in CVID remain largely unknown. Objective: This multicenter study aims to characterize the clinical profile of cancer in CVID patients in Spain and to identify independent risk factors associated with malignancy development, focusing on the role of immune dysregulation. Methods: A nationwide, cross-sectional study was conducted from November 2019 to May 2022, involving 17 hospitals treating PID patients in Spain. Data were collected systematically on demographics, infectious and non-infectious comorbidities, immunological parameters, and treatment. Statistical analysis, including multivariate logistic regression, was performed to identify risk factors associated to malignancy. Results: Of 250 CVID patients, 38 (15.26%) were diagnosed with cancer, predominantly non-Hodgkin lymphoma, gastric cancer, and lung adenocarcinoma. Cancer patients were significantly older (mean age 60.70 vs. 49.36 years, p<0.001) and had higher rates of immune dysregulation (81.58% vs. 59.7%, p=0.01). Immune dysregulation was an independent risk factor for cancer (OR 2.19, p=0.04), alongside previous immunosuppressant therapy (OR 2, p=0.031), higher IgM levels (OR 1.008 per SD, p=0.012), older age (OR 1.04, p<0.001), and lower CD4 cell counts at diagnosis (OR 0.997, p<0.001). Conclusions: This study highlights the increased cancer risk in CVID patients, with immune dysregulation, prior immunosuppressant use, elevated IgM levels, and lower CD4 cell counts as conjointly associated. These findings underscore the need for vigilant cancer screening and tailored management strategies in CVID patients to improve outcomes. Future research should focus on elucidating the molecular mechanisms linking immune dysregulation and malignancy in CVID.
Myb proteins repress human Ig epsilon germline transcription by inhibiting STAT6-dependent promoter activation.

S. Monticelli,R. Ghittoni,M. Kabesch,D. Vercelli

IF: 4.174

Molecular Immunology

Abstract:Cytokine-dependent induction of correctly spliced germline (GL) transcripts is required to target the appropriate switch region for class switch recombination. GL transcription is linked to the cell cycle and the number of cell divisions through mechanisms that have not been defined. The human proximal epsilon GL promoter contains an IL-4 responsive element (IL-4RE) that binds STAT6 and is sufficient to confer IL-4 inducibility to a heterologous promoter in transient transfection studies. We show herein that the IL-4RE contains a novel Myb binding motif that overlaps the 3' end of the STAT6 palindrome. EMSA analysis showed binding to the IL-4RE of endogenous Myb proteins expressed in BL-2 B cells and Jurkat T cells. However, double occupancy of a probe spanning both STAT6 and Myb binding motifs could not be detected. Thus, binding of either factor may prevent protein/DNA interactions at the other site, raising the possibility that Myb binding may interfere with STAT6-dependent activation of the IL-4RE. Indeed, cotransfection of A-Myb or c-Myb expression vectors in HEK293 and BL-2 cells suppressed STAT6-dependent transcription from a reporter construct containing four copies of the IL-4RE cloned upstream of a minimal thymidine kinase promoter. Most importantly, overexpression of A-Myb was sufficient to suppress IL-4-induced endogenous epsilon GL transcription in BL-2 cells. Our results indicate that Myb proteins, which are known to act as cell cycle sensors, may play an important mechanistic role in the in vivo regulation of epsilon GL transcription in human B cells.
Gut inflammation in CVID: causes and consequences

I M Andersen,S F Jørgensen

DOI: https://doi.org/10.1080/1744666X.2021.2008241

Abstract:Introduction: There is a wide spectrum of noninfectious gastrointestinal pathology, causing considerable morbidity and mortality in CVID, where both etiology and effective therapy are under debate. Areas covered: This review will focus on the noninfectious inflammation in the GI tract in CVID patients, covering the both the upper and lower GI tract inflammation, including the liver. The controversy of the CVID enteropathy definition and that of gluten-free diet for celiac-like disease in CVID will be discussed. Furthermore, the review will cover the link between GI inflammation and GI cancer. Finally, the role of gut microbiota, IgA, and genetics and its relationship with CVID enteropathy is scrutinized. The authors reviewed literature from PubMed. Expert opinion: The heterogeneity and the unknown mechanism behind CVID enteropathy, and thereby the lack of effective treatment, is one of the key challenges in the field of CVID. Celiac-like disease in CVID is due to immune dysregulation, and a gluten-free diet is therefore not indicated. Gut microbial dysbiosis and mucosal IgA can initiate systemic and local inflammation and is involved in the immune dysregulation in CVID. Considering the heterogeneity of CVID enteropathy, personalized medicine is probably the future for these patients.
Linking Microbiota Profiles to Disease Characterization in Common Variable Immunodeficiency: The Case of Granulomatous–Lymphocytic Interstitial Lung Disease

Marta Dafne Cabanero-Navalon,Miguel Carda-Diéguez,Pedro Moral Moral,Alex Mira,Héctor Balastegui-Martin,Miguel Salavert-Lletí,Victor Garcia-Bustos

DOI: https://doi.org/10.3390/biomedicines12102239

IF: 4.757

2024-10-02

Biomedicines

Abstract:Background and objectives: Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by decreased immunoglobulins and recurrent infections, with non-infectious complications such as granulomatous–lymphocytic interstitial lung disease (GLILD) affecting up to 30% of patients. Methods: Using high-throughput 16S rRNA gene sequencing, salivary, sputum, and fecal microbiome from CVID patients with GLILD, comparing them to CVID patients without GLILD—with immune dysregulation (dCVID) and only infections (iCVID)—and healthy controls was analyzed. Results: A total of 41 CVID patients, 7 with GLILD, and 15 healthy donors were included. Global fecal biodiversity was significantly lower in GLILD patients compared to CVID subgroups and controls. GLILD patients harbored different specific bacterial communities in all niches, with some keystone species common to dCVID. Conchiformibius, Micrococcales, and Capnocytophaga are more frequent in the sputum of GLILD patients. Saliva in GLILD shows higher frequencies of Conchiformibius and Haemophilusparainfluenzae. Fecal samples from GLILD patients have higher levels of Gemella morbilorum, Lacticaseibacillus, and Cellulosimicrobium. A non-assigned Conchiformibius spp. is consistently associated with GLILD across different niches and could be a potential pathobiont or relevant microbiological marker for GLILD. Cluster network and correlation analyses show profound dysbiosis in the sputum, saliva, and feces of GLILD patients. Conclusions: These findings highlight significant microbiome alterations in CVID patients with GLILD, particularly in the respiratory tract, suggesting a possible link to both local and systemic immune dysregulation.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency

Astrid C. van Stigt,Giulia Gualtiero,Francesco Cinetto,Virgil A.S.H. Dalm,Hanna IJspeert,Francesco Muscianisi

DOI: https://doi.org/10.1097/aci.0000000000001032

2024-10-10

Current Opinion in Allergy and Clinical Immunology

Abstract:The pathogenesis of granulomatous disease in common variable immunodeficiency (CVID) is still largely unknown, which hampers effective treatment. This review describes the current knowledge on the pathogenesis of granuloma formation in CVID and the biological basis of the current treatment options.

immunology,allergy
Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis

Hsi-En Ho,Charlotte Cunningham-Rundles

DOI: https://doi.org/10.3389/fimmu.2020.00149

2020-02-07

Abstract:Non-infectious complications in common variable immunodeficiency (CVID) have emerged as a major clinical challenge. Detailed clinical spectrum, organ-specific pathologies and associated sequelae from 623 CVID patients followed in New York since 1974 were analyzed, and recent insights to pathogenesis were reviewed. Non-infectious manifestations were present in 68.1% of patients, and they do not tend to be present in isolation. They include autoimmunity (33.2%), chronic lung disease (30.3%), lymphoid hyperplasia/splenomegaly (20.9%), liver disease (12.7%), granulomas (9.3%), gastrointestinal disease (7.3%), lymphoma (6.7%), and other malignancies (6.4%). In the lungs, interstitial disease and bronchiectasis were the most common findings, with lymphoma at this site being a rare (n = 6), but serious, manifestation. Bronchiectasis was not a prerequisite for the development of interstitial disease. In the liver, granulomas and nodular regenerative hyperplasia were the most common. Gastrointestinal disease may affect any segment of the intestinal tract, with lymphoid infiltrations and villous blunting being the leading histologic findings. With progression of organ-specific diseases, a wide spectrum of associated sequelae was observed. Lymphoma was more common in females (P = 0.036)-all B cell types except in one subject. Solid organ transplantations (liver, n = 5; lung, n = 4; combined lung and heart, n = 2) and hematopoietic stem cell transplantations (for B cell lymphoma, n = 1) have rarely been performed in this cohort, with mixed outcomes. Recent identification of monogenic defects, in ~10-30% of various CVID cohorts, has highlighted the molecular pathways that can affect both antibody production and broader immune regulation. In addition, cellular defects in both innate and adaptive immune systems are increasingly recognized in this syndrome.
Altered Spectrum of Lymphoid Neoplasms in a Single-Center Cohort of Common Variable Immunodeficiency with Immune Dysregulation

Claudia Wehr,Leonora Houet,Susanne Unger,Gerhard Kindle,Sigune Goldacker,Bodo Grimbacher,Andrés Caballero Garcia de Oteyza,Reinhard Marks,Dietmar Pfeifer,Alexandra Nieters,Michele Proietti,Klaus Warnatz,Annette Schmitt-Graeff

DOI: https://doi.org/10.1007/s10875-021-01016-4

Abstract:Purpose: Common variable immune deficiency (CVID) confers an increased risk of lymphoid neoplasms, but reports describing the precise WHO specification of the lymphoma subtypes and their immunological environment are lacking. We therefore classified lymphomas-occurring in a cohort of 21 adult CVID patients during a 17-year period at our center-according to the 2016 WHO classification and characterized the local and systemic immunological context RESULTS: The median time between the onset of CVID and lymphoma was 14 years. Patients showed a high prevalence of preceding immune dysregulation: lymphadenopathy (n = 13, 62%), splenomegaly (n = 18, 86%), autoimmune cytopenia (n = 14, 67%), and gastrointestinal involvement (n = 15, 71%). The entities comprised extranodal marginal zone lymphoma (n = 6), diffuse large B cell lymphoma (n = 7), plasmablastic lymphoma (n = 1), classic Hodgkin lymphoma (n = 4, including three cases with germline CTLA4 mutations), T cell large granular lymphocytic leukemia (n = 2), and peripheral T cell lymphoma, not otherwise specified (n = 1), but no follicular lymphoma. An Epstein-Barr virus association was documented in eight of 16 investigated lymphomas. High expression of PDL1 by tumor cells in five and of PDL1 and PD1 by tumor-infiltrating macrophages and T cells in 12 of 12 investigated lymphomas suggested a tolerogenic immunological tumor environment. Conclusion: In summary, a diverse combination of specific factors like genetic background, chronic immune activation, viral trigger, and impaired immune surveillance contributes to the observed spectrum of lymphomas in CVID. In the future, targeted therapies, e.g., PD1/PDL1 inhibitors in CVID associated lymphomas with a tolerogenic environment may improve therapy outcome.
Variable Expression Common Immune Deficiency: A Report of Five Cases

Abir Bouhamdi,Mounia Serraj,Mohamed Biaz,Mohamed Chakib Benjelloun,Bouchra Amara

DOI: https://doi.org/10.7759/cureus.61397

2024-05-30

Cureus

Abstract:We present five cases of common variable immunodeficiency (CVID), comprising three women and two men with a mean age of 23.8 ± 9.2 years. All our patients suffered from recurrent bronchopneumonitis, with complications of purulent pleurisy in two cases, requiring decortication in one case, and resulting in bronchiectasis in three cases. Digestive tract infections were observed in four patients, while two patients presented with ENT infections. One case was complicated by bacterial meningitis. All patients presented with global hypogammaglobulinemia, with CVID and granulomatous manifestation in one case. Treatment consisted of monthly immunoglobulin infusions.
Radical mastectomy with internal mammary lymph node dissection for melanoma of skin of breast.

G. Pack,R. Brasfield

DOI: https://doi.org/10.1001/ARCHSURG.1963.01310080038009

1963-02-01

Abstract:The principle of monobloc excision and dissection in continuity for primary cancers metastasizing into regionally adjacent lymph nodes has found general acceptance. It is employed for cancers of the oral group, e.g., lip, tongue, floor of mouth, inferior alveolus, for thyroid cancer, for certain cancers of the vulva and penis, for cancers of the uterine cervix and cancers of the rectum for which pelvic lymph node dissection is feasible. The first standardized application of this principle followed the independent descriptions of the so-called radical mastectomy by Halsted and Willy Meyer in 1894. The operation embodies the sacrifice of the viscus containing the primary cancer or an adequate removal of the tissue, e.g., skin, which contains it, together with a complete dissection of the adjacent and accessible regional lymph nodes into which metastases have occurred or might occur, and, which is equally important, the wide pathway of intervening tissues with the

Appreciating the best.

Self‐nonself discrimination and repertoire selection of human T cells differentiated in an HLA‐semiallogeneic environment following bone marrow transplantation for severe combined immunodeficiency

[The ultrastructure of the pineal body in the parakeet Melopsittacus undulatus with special reference to cellular types and their functions].

Photocatalytic oxidation of trace carbamazepine in aqueous solution by visible-light-driven Znln2S4: Performance and mechanism.

[Common Variable Immunodeficiency: Report of Two Cases and Literature Review].

Association Between Coeliac Disease and Risk of Any Malignancy and Gastrointestinal Malignancy

P232 Common variable immunodeficiency-associated enteropathy in consecutive patients from a tertiary hospital

Paucity of gastrointestinal plasma cells in common variable immunodeficiency

[Common variable immunodeficiency disorders: Part 2. Updated clinical manifestations and therapeutic management]

Evidence for possible increase of sodium channel open time and involvement of Na/Ca exchange by a new positive inotropic drug: OPC-8212.

On Branciari's theorem for weakly compatible mappings

Unmasking Common Variable Immunodeficiency: A Case Of Chronic Diarrhea

The impact of immune dysregulation on the risk of malignancy in common variable immunodeficiency: insights from a multicenter study

Myb proteins repress human Ig epsilon germline transcription by inhibiting STAT6-dependent promoter activation.

Gut inflammation in CVID: causes and consequences

Linking Microbiota Profiles to Disease Characterization in Common Variable Immunodeficiency: The Case of Granulomatous–Lymphocytic Interstitial Lung Disease

The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency

Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis

Altered Spectrum of Lymphoid Neoplasms in a Single-Center Cohort of Common Variable Immunodeficiency with Immune Dysregulation

Variable Expression Common Immune Deficiency: A Report of Five Cases

Radical mastectomy with internal mammary lymph node dissection for melanoma of skin of breast.